Metabolic Conditions: Clinical Outcomes in Real-World Studies
Moderator
Sandhya Mehta, MS, PhD, Celgene, Summit, NJ, United States
This session explores the metabolic revolution by shifting focus from simple weight loss to hard clinical endpoints through high-quality research. Utilizing target trial emulations and pragmatic randomized designs, these studies demonstrate how GLP-1 and SGLT2 therapies significantly reduce mortality and cardiovascular risk across Medicare and complex chronic disease populations.